Yizhong Zhu

This inventor holds 6 USPTO granted patents and 3 published patent applications and 3 EPO patents. Top assignees: Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Centaurus Biopharma Co., Ltd., Lianyungang Runzhong Pharmaceutical Co., Ltd.. Active years: 2018-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yizhong Zhu. Retrieved from https://idiyas.com/inventor/yizhong-zhu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 6 (Patent Applications = 3)

% Patents Active = 83.3

EPO Patents = 3 (Patent Applications = 7)

Average Co-Inventor Count = 7.5

ph-index = 1

Forward Citations = 2(Granted Patents)

Location History:

Lianyungang, CN (2018 - 2020)
Jiangsu, CN (2019 - 2021)

Company Filing History:

6 out of 121

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

patents

4 out of 33

Centaurus Biopharma Co., Ltd.

patents

2 out of 26

Lianyungang Runzhong Pharmaceutical Co., Ltd.

patents

where one patent can have more than one assignee

Years Active: 2018-2025

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12371431 - Trifluoromethyl-substituted sulfonamide as BCL-2-selective inhibitor (2025-07-29),

2. 11098060 - Macrocycle containing aminopyrazole and pyrimidine and pharmaceutical composition and use thereof (2021-08-24),

3. 10858340 - Crystal of salt of quinazoline derivative (2020-12-08),

4. 10501468 - Method for preparing intermediate of 6-arylaminopyridonecarboxamide compound as MEK inhibitor (2019-12-10),

5. 10376512 - Crystal of aniline pyrimidine compound of trifluoroethyl substituted indole and salt thereof (2019-08-13),

6. 10023582 - 6-aryl amino pyridone formamide compound crystal and preparation method therefor (2018-07-17),

Title: Yizhong Zhu: Innovator in Pharmaceutical Chemistry

Introduction

Yizhong Zhu is a prominent inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific diseases. With a total of six patents to his name, Zhu's work is recognized for its potential impact on medical treatments.

Latest Patents

Zhu's latest patents include a trifluoromethyl-substituted sulfonamide as a BCL-2-selective inhibitor. This invention discloses a compound that can be used to treat anti-apoptotic BCL-2-related diseases, such as cancer. Another notable patent is a macrocycle containing aminopyrazole and pyrimidine, which is designed to inhibit tropomyosin receptor kinase (Trk) activity. This compound has potential applications in treating diseases mediated by Trk in mammals.

Career Highlights

Throughout his career, Yizhong Zhu has worked with several notable companies, including Chia Tai Tianqing Pharmaceutical Group Co., Ltd. and Centaurus Biopharma Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas in pharmaceutical research.

Collaborations

Zhu has collaborated with various professionals in his field, including colleagues such as Fei Liu and Lulu Wang. These collaborations have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Yizhong Zhu is a distinguished inventor whose work in pharmaceutical chemistry has the potential to revolutionize treatments for serious diseases. His innovative patents and collaborations highlight his commitment to advancing medical science.

Profile summary based on public USPTO records.